Dana Investment Advisors Inc. decreased its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 11.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 409,291 shares of the company's stock after selling 50,532 shares during the quarter. Dana Investment Advisors Inc. owned 1.01% of Phibro Animal Health worth $8,595,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the business. Rhumbline Advisers raised its stake in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock worth $1,608,000 after buying an additional 484 shares during the period. Los Angeles Capital Management LLC raised its position in Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock worth $505,000 after acquiring an additional 503 shares during the period. BNP Paribas Financial Markets lifted its holdings in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares in the last quarter. New York State Teachers Retirement System grew its position in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares during the period. Finally, SG Americas Securities LLC grew its position in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after purchasing an additional 906 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.
Phibro Animal Health Price Performance
PAHC traded up $0.33 on Friday, reaching $23.64. 339,958 shares of the company's stock were exchanged, compared to its average volume of 253,645. Phibro Animal Health Co. has a twelve month low of $11.98 and a twelve month high of $26.55. The stock has a market cap of $957.49 million, a PE ratio of 49.25, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock's fifty day moving average price is $22.47 and its 200-day moving average price is $22.51.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.
Analyst Ratings Changes
A number of brokerages recently weighed in on PAHC. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. StockNews.com cut Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Friday. Finally, Barclays lifted their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $21.00.
Check Out Our Latest Report on Phibro Animal Health
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
